Association of meningioma with reproductive factors

International Journal of Cancer

Volumn 119, Issue 5, 2006, Pages 1152-1157

  Lee, Eunsuk ^a   Grutsch, James ^a,b   Persky, Victoria ^a   Glick, Roberta ^a,c   Mendes, Juliana ^a   Davis, Faith ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Midwestern Regional Medical Center   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Case control; Hormonal; Meningioma; Reproductive

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BACKACHE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENARCHE; MENINGIOMA; MENOPAUSE; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTION; THYROID DISEASE;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENARCHE; MENINGEAL NEOPLASMS; MENINGIOMA; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARITY; PREGNANCY; REPRODUCTION; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 33746362955     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21950     Document Type: Article

References (48)

1. Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer 2002;94:1626-35.
2. Roelvink NCA, Kamphorst W, Vanalphen HAM, Rao BR. Pregnancy-related primary brain and spinal tumors. Arch Neurol 1987;44: 209-15.
3. Glick RP, Molteni A, Fors EM. Hormone binding in brain tumors. Neurosurgery 1983;13:513-9.
4. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997;86:113-20.
5. Black PM. Hormones, radiosurgery and virtual reality: new aspects of meningioma management. Can J Neurol Sci 1997;24:302-6.
6. Wahab M, Al Azzawi F. Meningioma and hormone influences. Climacteric 2003;6:285-92.
7. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 2004;57:1033-7.
8. Grunberg SM. Role of antiprogestational therapy for meningiomas. Hum Reprod 1994;9:202-7.
9. Olson JJ, Beck DW, Schlechte J, Loh PM. Hormonal manipulation of meningiomas in vitro. J Neurosurg 1986;65:99-107.
10. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer 1992;69:2541-7.
11. Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev 1995;4:333-9.
12. Schlehofer B, Blettner M, Wahrendorf J. Association between brain-tumors and menopausal status. J Natl Cancer Inst 1992;84:1346-9.
13. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J Neurosurg 2003;99:848-53.
14. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005;114:797-805.
15. Central Brain Tumor Registry of the United States (CBTRUS). Statistical report: primary brain tumors in the United States, 1997-2001. CBTRUS, Chicago, Illinois, 2004.
16. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER, Jr. Factors associated with survival in patients with meningioma. J Neurosurg 1998;88:831-9.
17. Centers for Disease Control. Epi Info Version 5: a word processing, database, and statistics system for epidemiology on microcomputers. CDC, U.S. Department of Health and Human Service. Atlanta, Georgia, 1990.
18. National Center for Chronic Disease Prevention and Health Promotion. Nutrition and Physical Activity. National Center for Chronic Disease Prevention and Health Promotion, 2003. Available at www.cdc.gov (accessed on April 29, 2003).
19. Preston-Martin S, Descriptive epidemiology of primary tumors of the brain, cranial nerves, and cranial meninges. Neuroepidemiology 1989; 8:283-95.
20. Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C. Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 1980;65:67-73.
21. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002;94:1555-63.
22. Sadetzki S, Modan B, Chetrit A, Freedman L. An iatrogenic epidemic of benign meningioma. Am J Epidemiol 2000;151:266-72.
23. Grutsch J, Lis C, Propp J, McCarthy BJ. Is menopause protective in the development of meningiomas. Keystone: Society of Neurooncology, 2003. (Abstract EP-04).
24. Bickerstuff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958;21:89-91.
25. Michelsen JJ, New PF. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 1969;32:305-7.
26. Lambe M, Coogan P, Baron J. Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 1997;72:389-93.
27. Speirs V, BoyleWalsh E, Fraser WD. Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int J Cancer 1997;72:714-9.
28. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000;74:357-64.
29. Phillips LE, Longstreth WT, Koepsell T, Custer BS, Kukull WA, van Belle G. Active and passive cigarette smoking and risk of intracranial meningioma-a population-based case-control study. Neuroepidemiology 2005;24:117-22.
30. Konstantinidou AE, Korkolopoulou P, Mahera H, Kotsiakis X, Hranioti S, Eftychiadis C, Patsouris E. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 2003;43:280-90.
31. Gocze PM, Szabo I, Freeman DA. Influence of nicotine, cotinine, anabasine and cigarette smoke extract on human granulosa cell progesterone and estradiol synthesis. Gynecol Endocrinol 1999;13:266-72.
32. Vrsanska S, Nagyova E, Mlynarcikova A, Fickova M, Kolena J. Components of cigarette smoke inhibit expansion of oocyte-cumulus complexes from porcine follicles. Physiol Res 2003;52:383-7.
33. Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992;51:20-7.
34. Hu J, Little J, Xu T, Zhao X, Guo L, Jia X, Huang G, Bi D, Liu R. Risk factors for meningioma in adults: a case-control study in northeast China. Int J Cancer 1999;83:299-304.
35. Choi NW, Schuman LM, Gullen WH. Epidemiology of primary central nervous system neoplasms. II. Case-control study. Am J Epidemiol 1970;91:467-85.
36. Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE. Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989;8:266-75.
37. Helseth A, Mork SJ, Glattre E. Neoplasms of the central nervous system in Norway. V. Meningioma and cancer of other sites. An analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986. APMIS 1989;97:738-44.
38. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155-60.
39. Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins. Lyon: IARC, 1991. IARC Scientific Publications No. 105, 197-203.
40. Phillips L, Benghuzzi H, Cason Z, Tucci M. The effect of agonists and antagonists on Hep-2 cells. J Neurooncol 2005;41:135-40.
41. Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 2004;68: 57-69.
42. Honegger J, Bucholder M, Schrell U, Adams EF, Fahlbusch R. The coexistence of pituitary adenomas and meningiomas: three case reports and a review of the literature. Br J Neurosurg 1989;3:59-69.
43. Irsy G, Goth M, Slovik F, Balint K, Szabolcs I, Pasztor E, Szilagyi G. Growth hormone producing pituitary adenoma and meningioma. Zentralbl Neurochir 1985;46:337-43.
44. Cannavo S, Curto L, Fazio R, Paterniti S, Blandino A, Marafioti T, Trimarchi F. Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case-report and review of the literature. J Endocrinol Invest 1993;16:703-8.
45. Furth J, Clifton KH. Experimental pituitary tumors and the role of pituitary hormones in tumorigenesis of the breast and thyroid. Cancer 1957;10:842-53.
46. Bellur SN, Chandra V, Anderson RJ. Association of meningiomas with obesity. Ann Neurol 1983;13:346-7.
47. Azcoitia I, Garcia-Ovejero D, Chowen JA, Garcia-Segura LM. Astroglia play a key role in the neuroprotective actions of estrogen. Prog Brain Res 2001;132:469-78.
48. Garcia-Segura LM, Azcoitia I, Doncarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.